文献速递肝胆胰外科围术期管理与 ERAS

复杂肝胆胰手术后30天再入院评估不足

Thirty days are inadequate for assessing readmission following complex hepatopancreatobiliary procedures.
PubMed 文献 · Surg Endosc · 2018-12-10

本研究利用纽约州数据库分析2010-2012年6207例复杂肝胆胰手术患者,随访2年发现30天再入院率为20.49%,但后续再入院持续发生,提示30天窗口不足以全面评估再入院。

要点

  • 复杂肝胆胰手术后30天再入院率为20.49%,但2年内再入院持续发生。
  • 30天再入院是后续再入院的预测因素,但不足以反映总再入院负担。
  • 胰腺切除和胆囊手术患者30天再入院风险高于肝切除患者。

核心结论

  • 30天再入院窗口是复杂肝胆胰手术后总再入院的不充分但具有预测性的指标。

研究设计与样本

  • 回顾性队列研究,利用纽约州规划与研究合作系统数据库,纳入2010-2012年6207例复杂肝胆胰手术患者,随访2年。

主要发现

  • 1272例(20.49%)发生非计划30天再入院,816例(13.15%)发生31-90天再入院,1678例(27.03%)发生91天至1年再入院,1404例(22.62%)发生1-2年再入院。
  • 30天再入院的危险因素包括手术类型(胰腺切除和胆囊手术患者比肝切除患者更可能再入院)、机构类型(学术中心更可能再入院)、男性、任何合并症及围术期并发症。
  • 31-90天再入院的危险因素包括种族、保险分组、任何合并症或围术期并发症及30天再入院。
  • 91天至1年再入院的危险因素包括男性、种族、任何合并症、30天再入院及31-90天再入院。
  • 1-2年再入院的危险因素包括任何合并症及既往91天至1年再入院。

临床怎么用

  • 临床应关注复杂肝胆胰手术后30天以上的再入院风险,尤其对于有合并症、围术期并发症及既往再入院的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Early readmissions (30 days) have been used as a measure of health care quality. The purpose of our study was to evaluate patterns of readmission for a longer period (up to 2 years) following Hepatopancreatobiliary (HPB) surgery in the state of New York. METHODS: The State Planning and Research Cooperative System database was utilized to identify patients undergoing complex HPB procedures between 2010 and 2012. Patients were followed for 2 years following surgery to identify all-cause readmissions. Factors for readmissions included patient demographics, comorbidities, perioperative complications, surgery type, and academic status. Multivariable generalized linear mixed models were performed to evaluate risk factors for readmissions. RESULTS: There were 6207 complex HPB procedures with 1272 (20.49%) unplanned 30-day readmissions, 816 (13.15%) unplanned 31-90-day readmissions, 1678 (27.03%) unplanned 91-day to 1-year readmissions, and 1404 (22.62%) 1-2-year readmissions. After adjusting for other possible confounding factors, risk factors for 30-day readmissions include surgery type, as pancreatectomy and gallbladder patients are more likely to have a 30-day readmission than hepatectomy patients, facility type, as academic centers are more likely to have a readmission, male gender, presence of any comorbidity, and peri-operative complications. Risk factors for 31-90-day readmissions include race, insurance group, any comorbidity or any peri-operative complication, and 30-day readmissions. Risk factors for 91-day to 1-year readmissions include male gender, race, any comorbidity, 30-day readmissions, and 31-90 days' readmissions. Risk factors for 1-2-year readmissions include presence of any comorbidity, and previous 91-day to 1-year readmissions. CONCLUSION: The 30-day readmission window is an inadequate, but predictive, measure of total readmission following complex HPB procedures.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Altieri MS, Yang J, Yin D, et al. Thirty days are inadequate for assessing readmission following complex hepatopancreatobiliary procedures. Surg Endosc. 2018. PMID: 30535541. doi:10.1007/s00464-018-6539-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。